openPR Logo
Press release

An Overview Analysis on Asia-Pacific Monoclonal Antibodies Market 2016-2021

06-05-2017 01:12 PM CET | Health & Medicine

Press release from: Market Data Forecast

Browse And Choose From Our World Class Research Reports

Browse And Choose From Our World Class Research Reports

Asia-Pacific Monoclonal Antibodies Market is estimated to be $10397.7073 million in 2016 and expected to grow at a Compound Annual Growth Rate of 4.52%, to reach $12969.84 million by 2021.

View report at: http://www.marketdataforecast.com/market-reports/asia-pacific-monoclonal-antibodies-market-1187/

MAb`s are antibodies that are made by identical immune cells that are all clones of a unique parent cell, in distinction to polyclonal antibodies, which are made by numerous different immune cells. Monoclonal Antibodies market in Asia-Pacific region is gaining momentum due to increasing awareness among patients and physicians about application of mAb`s in various diseases.

Free Sample for report: http://www.marketdataforecast.com/market-reports/asia-pacific-monoclonal-antibodies-market-1187/request-sample

Asia-Pacific Monoclonal Antibodies market is driven by factors such as patent expiries of key biological drugs, aging population, increasing disposable income, and supporting legislations. The development of new molecules is also expected to play a key role in the future of the market. Rising government initiatives supporting the use of mAbs for research and treatment purposes along with an upsurge in R&D activities for the development of cost-effective therapeutic mAbs are also driving the market for Monoclonal Antibodies market. However, amount of money and time required for the identification and development of potential molecules is huge and is a major factor restraining the market growth.

Asia-Pacific market for Monoclonal Antibodies is broadly segmented into Source, Indication, End User and Application. Based on source, the market is segmented into Murine, Chimeric, Humanized and Human. Human mAb`s accounted for the largest share of the market with a share of approximately XX%. On the basis of indication, the Asia-Pacific mAb`s market is categorized into cancer, Auto immune diseases, Infectious diseases, Cardiovascular diseases, CNS disorders and others. Cancer Vaccines are further sub segmented into Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer and Others. By end user, the market is segmented into Hospitals/Clinics, Research Institute and Diagnostic Laboratories. Hospitals is the largest end user segment accounting for a share of approximately XX% while diagnostic laboratories are estimated to be the fastest growing due to its increasing applications. On the basis of application Asia-Pacific monoclonal antibodies market is segmented into medical and experimental. By experimental application the market is further sub segmented into Western Blot, ELISA, Radioimmune Assays, Immunofluorescence and others.

Buy now: https://www.marketdataforecast.com/cart/buy-now/asia-pacific-monoclonal-antibodies-market-1187

Asia-Pacific is the fastest growing region for Monoclonal antibodies market owing to huge population and increasing disposable income of people. Geographically Asia-Pacific monoclonal antibodies market is segmented into China, India, Japan, South Korea and Australia. Within Asia-Pacific, China is the largest market while India is estimated to be the fastest growing.

Some of the major companies dominating the market, by their products include GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Innovent Biologics (China), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland) and Shanghai Junshi Bioscience Co.,Ltd. (China).

Scope of the Report:

•Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

•Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

•Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

•Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

•A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

•An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

•Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

About Market Data Forecast:
The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release An Overview Analysis on Asia-Pacific Monoclonal Antibodies Market 2016-2021 here

News-ID: 563917 • Views:

More Releases from Market Data Forecast

Middle East and Africa Steel Rebar Market Sees Explosive Growth Globally
Middle East and Africa Steel Rebar Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the middle east steel rebar market was worth US$ 8.59 billion in 2023 and is anticipated to reach a valuation of US$ 13.19 billion by 2029 and it is predicted to register a CAGR of 7.4% during the forecast period 2024-2029. the Middle East is driving strong demand for steel rebar, the backbone of reinforced concrete. This growth is fueled
Middle East and Africa Industrial Lubricants Market Share, Industry Analysis & Forecast Report 2024-2029.
Middle East and Africa Industrial Lubricants Market Share, Industry Analysis & F …
According to the latest research report published by Market Data Forecast, the middle east and africa industrial lubricants market was worth US$ 18.51 billion in 2023 and is anticipated to reach a valuation of US$ 22.62 billion by 2029 and it is predicted to register a CAGR of 3.4% during the forecast period 2024-2029. Industrial lubricants in the Middle East and Africa are specialized substances vital for reducing friction and wear
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2029.
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2 …
According to the latest research report published by Market Data Forecast, the global steam methane reforming market size was valued at USD 691.67 million in 2023 and is projected to reach USD 1004.13 million by 2029, growing at a CAGR of 6.41% during the forecast period 2024 to 2029. Steam reforming of methane mainly involves two reactions: the water gas shift reaction and the reforming reaction. In the latter case, natural
Telecom Tower Market is set for a Potential Growth
Telecom Tower Market is set for a Potential Growth
According to the latest research report published by Market Data Forecast, the global telecom tower market is predicted to reach USD 3.74 billion in 2024 and USD 7.07 billion by 2029, growing at a CAGR of 13.59% during the forecast period. Telecom towers are the backbone of any mobile telecommunications system. The telecom tower is a structure that houses a transceiver to maintain connection with thousands of mobile phones and the

All 5 Releases


More Releases for Monoclonal

Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,
Monoclonal Antibodies Market Outline and Updates..!!
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into
Global Monoclonal Antibody Diagnostic Reagents Market
Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515 Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity